OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Personalized Strategies for Advanced Colorectal Cancers

home / peer-exchange / personalized-strategies-advanced-crc
Adjuvant Therapy for Stage II and III Colon Cancer

EP. 1: Adjuvant Therapy for Stage II and III Colon Cancer

July 10th 2019
Molecular Profiling in Stage II and III Colon Cancer

EP. 2: Molecular Profiling in Stage II and III Colon Cancer

July 10th 2019
Adjuvant Treatment or "Watch and Wait" in Stage II CRC

EP. 3: Adjuvant Treatment or "Watch and Wait" in Stage II CRC

July 10th 2019
IDEA Collaboration; Impact on Adjuvant Therapy

EP. 4: IDEA Collaboration; Impact on Adjuvant Therapy

July 10th 2019
Changing Paradigms for Rectal Cancer

EP. 5: Changing Paradigms for Rectal Cancer

July 10th 2019
Molecular Testing in 2019 for mCRC

EP. 6: Molecular Testing in 2019 for mCRC

July 10th 2019
Frontline Therapy for mCRC

EP. 7: Frontline Therapy for mCRC

July 10th 2019
TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC

EP. 8: TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC

July 10th 2019
Colon Cancer in Young Patients

EP. 9: Colon Cancer in Young Patients

July 10th 2019
Management of Colorectal Cancer Metastases

EP. 10: Management of Colorectal Cancer Metastases

July 10th 2019
Maintenance Therapy for mCRC

EP. 11: Maintenance Therapy for mCRC

July 10th 2019
New Therapy Options for BRAF-Mutated mCRC

EP. 12: New Therapy Options for BRAF-Mutated mCRC

July 10th 2019
Salvage Therapy for mCRC

EP. 13: Salvage Therapy for mCRC

July 10th 2019
Immunotherapy in CRC

EP. 14: Immunotherapy in CRC

July 10th 2019
Future Directions in I/O Therapy for mCRC

EP. 15: Future Directions in I/O Therapy for mCRC

July 10th 2019

Latest Conference Coverage

Epcoritamab Plus R-ICE Yields High CR Rates and Improves Transplant Eligibility in R/R DLBCL

Fixed-Duration Epcoritamab Plus Pola-R-CHP Demonstrates Durable Efficacy in First-Line DLBCL

Consolidation Blinatumomab Improves Efficacy Vs Chemo in Newly Diagnosed BCR::ABL1– B ALL

BGB-16673 Is Safe, Elicits Nearly 85% ORR in Relapsed/Refractory CLL/SLL

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact